1,387,672 1,773, % 927,421 1,278, % 828,941 1,598, % 735,968 1,451, % (547,048) 735, , % 66.8% 72.1% 53.0% 81

Similar documents
01 cover D 0..1

i


A

i

i


+/(-) 3,470,397 3,337,944 +4% 1,391,402 1,532,973-9% 4,535,945 4,576,515-1% +/(-) % 2

untitled

untitled

目 錄 ii

untitled

i

女性减肥健身(一).doc

IRA (Chi).indd

1, , ,363 18, ,235 30,046 47,292 48,525 48,443 49, ,621 29,344 3,699 4,836 6,535 39,457 39,578 7,835 8,947 8,986 9,508

NWSH Results Announcement Jun 14 Chi (Final)

, ,414 (682,150) (632,696) 135, , ,174 2,306 (131) (49,336) (48,034) (79,460) (7

服务协议


untitled

C Ann.indd

目 錄 年 報 2014

C Ann.indd

ii

5% 14A 0.1% 5% 14A 2

The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation

Smartone_C_GM Cir.indb



China Ocean_C_DT Cir.indb

i

12548-China Grand IR15_C.indd

Microsoft Word - edu-re~1.doc

Microsoft Word - 發布版---規範_全文_.doc

概 述 随 着 中 国 高 等 教 育 数 量 扩 张 目 标 的 逐 步 实 现, 提 高 教 育 质 量 的 重 要 性 日 益 凸 显 发 布 高 校 毕 业 生 就 业 质 量 年 度 报 告, 是 高 等 学 校 建 立 健 全 就 业 状 况 反 馈 机 制 引 导 高 校 优 化 招

鱼类丰产养殖技术(二).doc

疾病诊治实务(一)

名人养生.doc

<4D F736F F D2040B9C5B871A661B0CFABC8AE61C2A7AB55ACE3A8735FA7F5ABD8BFB3B9C5B871A661B0CFABC8AE61C2A7AB55ACE3A8732E646F63>


中老年保健必读(十).doc

27 i

% % ,542 12,336 14,53 16,165 18,934 22,698 25, ,557 7,48 8,877 11, 13,732 17,283 22,

海淀区、房山区(四)

穨ecr1_c.PDF

穨2005_-c.PDF

北京理工大学.doc

尲㐵.⸮⸮⸮⸮⸮

东城区(下)

果树高产栽培技术(一).doc

物质结构_二_.doc

第一節 研究動機與目的

i

水力发电(九)

中国古代文学家(八).doc

景观植物(一)

Microsoft Word - 目录.doc

园林植物卷(三).doc

19q indd

厨房小知识_一_

中南财经大学(七).doc


赵飞燕外传、四美艳史演义

1. 本文首段的主要作用是 A. 指出 異蛇 的藥用功效 說明 永之人爭奔走焉 的原因 B. 突出 異蛇 的毒性 為下文 幾死者數矣 作鋪墊 C. 交代以蛇賦稅的背景 引起下文蔣氏有關捕蛇的敘述 2. 本文首段從三方面突出蛇的 異 下列哪一項不屬其中之一 A. 顏色之異 B. 動作之異 C. 毒性之

第三章

Microsoft Word - 08 单元一儿童文学理论

南華大學數位論文

Microsoft Word 一年級散文教案.doc

項 訴 求 在 考 慮 到 整 體 的 財 政 承 擔 以 及 資 源 分 配 的 公 平 性 下, 政 府 採 取 了 較 簡 單 直 接 的 一 次 性 減 稅 和 增 加 免 稅 額 方 式, 以 回 應 中 產 家 庭 的 不 同 訴 求 ( 三 ) 取 消 外 傭 徵 費 6. 行 政 長

(f) (g) (h) (ii) (iii) (a) (b) (c) (d) 208

i -

untitled


i


, ,249 (164,579) (77,591) 128, ,658 31,085 13,783 (67,320) (60,839) (118,382) (60,344) (24,438) (52,355)

untitled

untitled


93,685 51,256 3,320 2, ,929 11,132 (753) 168,934 64, ,461 6, ,045 36, , , , , , ,158 9


/0 8

A 1..8


C Ann.indd

,787,321 6,292,569 (3,178,103) (3,422,560) 2,609,218 2,870, ,824 85,775 (1,766,182) (2,108,497) (477,730) (536,273) (79,000) (98,0

Microsoft Word - CW_8169ann doc

115,872, % 42.3%21,150, % 2


375,000, % 648,000, ,000, ,000, ,000, % ,000,000 2

最新监察执法全书(一百五十四).doc

位元堂藥業控股有限公司

14 14A 重 組 協 議 重 組 及 增 加 昆 山 維 信 諾 之 註 冊 資 本 股 權 持 有 人 所 擁 有 之 註 冊 資 本 狀 況 % 190, , , ,

(A) 61.24% 30.62% (B) 90% 10% 50% (C) 90% 10% 30% 70% (D) 90% 10% 30% 70% 2

* % 268, ,789 (12.3) 38,091 87,053 (56.2) 44,533 44, , ,036 (19.7) * % 138, , ,397 31,975 (45.6) 24,303 22,596 7.

untitled

280,000, % 0.003% 0.005% C

(Project Dragonleap)_Chi.indb

C Ann.indd

Transcription:

SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. 0460 2410 34 1

1,387,672 1,773,521-21.8% 927,421 1,278,850-27.5% 828,941 1,598,783-48.2% 735,968 1,451,550-49.3% (547,048) 735,968 904,502-18.6% 66.8% 72.1% 53.0% 81.9% 7.10 14.01 62 63 98 73 1.4 1.4 21.8% 1,387.7 1,773.5 66.8% 72.1% GMP 49.3% 736.0 1,451.6 547.0 18.6% 7.10 14.01 1.4 2

4 2,062,618 2,051,370 4 29,992 30,881 4 2,797,141 2,817,065 4 587,211 596,407 8 1,203,910 1,189,118 5 21,974 18,146 6 4,000 167,753 171,075 6,874,599 6,874,062 265,892 233,028 7 746,989 972,267 2,484,111 1,959,280 2,678,311 2,282,370 6,175,303 5,446,945 13,049,902 12,321,007 3

9 85,126 85,610 9 5,493,576 5,574,848 184,689 172,541 5,534,858 5,262,640 11,298,249 11,095,639 81,928 96,093 11,380,177 11,191,732 5 86,285 125,876 12 60,541 61,220 8,280 8,280 155,106 195,376 11 1,294,706 664,308 181,077 217,696 12 38,836 51,895 1,514,619 933,899 1,669,725 1,129,275 13,049,902 12,321,007 4

13 1,387,672 1,773,521 (460,251) (494,671) 927,421 1,278,850 13 23,733 19,821 13 150,311 615,256 (55,862) (61,929) (216,662) (253,215) 13 828,941 1,598,783 49,763 71,920 (900) (292) 48,863 71,628 8 12,664 11,871 890,468 1,682,282 14 (172,516) (240,534) 717,952 1,441,748 735,968 1,451,550 (18,016) (9,802) 717,952 1,441,748 15 7.10 14.01 5

717,952 1,441,748 35,111 24,475 (25,280) (13,031) 9,831 11,444 727,783 1,453,192 745,799 1,462,994 (18,016) (9,802) 727,783 1,453,192 6

85,610 5,574,848 151,897 3,479,322 9,291,677 114,336 9,406,013 1,451,550 1,451,550 (9,802) 1,441,748 11,444 11,444 11,444 11,444 1,451,550 1,462,994 (9,802) 1,453,192 6,805 6,805 6,805 30,338 30,338 8,027 8,027 (11,350) 11,350 (72,326) (72,326) (890) (890) (3,517) (4,407) 85,610 5,574,848 157,906 4,942,222 10,760,586 67,056 10,827,642 7

85,610 5,574,848 172,541 5,262,640 11,095,639 96,093 11,191,732 735,968 735,968 (18,016) 717,952 9,831 9,831 9,831 9,831 735,968 745,799 (18,016) 727,783 10 2,297 2,297 2,297 (484) (81,272) (81,756) (81,756) 16 (463,750) (463,750) (463,750) 20 20 3,851 3,871 85,126 5,493,576 184,689 5,534,858 11,298,249 81,928 11,380,177 8

1,058,363 573,322 (580,561) 351,635 (81,861) 7,930 395,941 932,887 2,282,370 1,359,094 2,678,311 2,291,981 9

1. Plenty Gold Enterprises Limited Plenty Gold Clarendon House, 2 Church Street, P.O. Box HM 1022, Hamilton HM DX, Bermuda 2000 21 100025 2. 2.1 2.2 34 10

2.3 3. 10% 90% 11

4. 2,051,370 30,881 569,337 2,247,728 596,407 91,573 44,068 (2) (80,323) (889) (54,766) (9,196) (9,226) 2,062,618 29,992 549,413 2,247,728 587,211 1,704,128 32,659 588,775 2,226,936 362,364 142,291 31,621 20,423 121,989 8,050 20,792 (11,481) (3,565) (61,470) (889) (53,609) (4,952) 1,895,457 31,770 574,837 2,247,728 374,270 820,701,000 645,552,000 401,822,000 419,426,000 12

5. 1 18,146 61,906 3,828 (40,508) 21,974 21,398 2) 125,876 130,390 (2,591) 2,641 (37,000) 86,285 133,031 6. 4,000 10% 5% 13

7. 83,378 99,512 339,038 426,254 129,418 112,513 (a) 12,000 25,953 (b) 72,834 71,167 (c) 40,000 70,321 185,689 45,782 5,397 746,989 972,267 (a) 12,000,000 4.35% (b) 69,400,000 3,433,854 4.75% (c) 14

3 82,677 69,007 3 6 130 116 6 12 52 6,745 12 519 23,644 83,378 99,512 8. 502,637 470,503 701,273 718,615 1,203,910 1,189,118 15

(a) 470,503 358,491 (i) 65,563 102,720 (ii) 3,050 (iii) (26,485) (9,994) (9,748) 502,637 451,463 (i) 65,563,000 38.1% (ii) 50,000 49.0% 3,000,000 33.0% (iii) 24.3% 3,851,000 16

(b) 718,615 637,500 (40,000) 22,658 21,619 701,273 659,119 9. 0.01 10,364,182 85,610 5,574,848 5,660,458 (i) (58,633) (484) (81,272) (81,756) 0.01 10,305,549 85,126 5,493,576 5,578,702 (i) 58,633,000 96,461,229 81,756,000 17

10. (i) Plenty Gold MSPEA Pharma Holdings B.V. Plenty Gold Plenty Gold 33,750,000 MSPEA Pharma Holdings B.V. 3,750,000 A 3.19 14,150 B 3.19 19,750 C 0.70 2,050 35,950 18

1 1 3.19 2,084 3.19 4,167 3.19 18,066 3.19 36,133 0.70 2,050 0.70 4,100 22,200 44,400 234 1.57 31,448,172 0.01 234 A B 1.57 31,448 19

(ii) A 3.19 4,167 4,167 3.19 (4,167) 4,167 B 3.19 28,668 28,668 3.19 (1,387) 3.19 (27,281) 28,668 C 0.70 4,100 4,100 0.70 (4,100) 4,100 20

A B 1.57 31,448 1.57 (2,333) 29,115 3.19 4,167 0.70 4,100 3.19 28,668 1.57 29,115 29,115 36,935 2,297,000 6,805,000 21

11. (i) 143,775 72,624 207,603 203,174 66,787 76,844 (ii) 7,800 24,834 (ii) 25,168 6,600 (ii) 4,481 4,481 159,822 155,756 463,750 53,862 38,327 51,404 5,074 25,482 26,816 84,772 49,778 1,294,706 664,308 (i) 46,848,000 37,950,000 (ii) 6 137,378 70,488 6 12 4,315 80 1 2,082 2,056 22 143,775 72,624

12. (a) 82,885 77,831 (b) 16,492 35,284 99,377 113,115 (a) 36,731 34,156 (b) 2,105 17,739 38,836 51,895 60,541 61,220 (a) (b) 23

13. 1,379,678 1,773,521 7,994 1,387,672 1,773,521 22,017 19,166 1,716 655 23,733 19,821 547,048 (i) 119,361 64,160 (ii) 34,073 (iii) (9,226) 3,851 2,252 4,048 150,311 615,256 130,661 107,542 14,513 13,378 59,832 94,317 (i) (ii) (iii) 24

14. 178,935 197,385 178,935 197,385 (6,419) 43,149 (6,419) 43,149 172,516 240,534 (a) (i) (ii) (iii) 25% 15% 25

(iv) 10% 10% 5% 15. (a) 735,968 1,451,550 10,361,852 10,364,182 7.10 14.01 (b) 16. 1.4 1.4 140,228 145,099 26

1.4 4.5 463,750,000 1.4 1.4 17. (i) 493,214,000 289,298,000 (ii) 9.5% 27

(I) 2016 26 1 11 21.8% 49.3% 18.6% 11.9% 1 28

(i) (a) 94.6% 21.7% 40.5% 28.8% 366,872 218,218-40.5% 454,587 323,834-28.8% 218,387 219,965 0.7% B(II) 62,150 60,318-2.9% 110,299 101,328-8.1% 138,772 130,051-6.3% GM1 102,749 79,907-22.2% 57,950 55,682-3.9% 44,570 32,077-28.0% 37,472 25,505-31.9% 72,515 52,761-27.2% 1,727 909-47.4% 29

(b) 77.0% 234.5% 5.8% 11,081 11,718 5.8% 29,372 24,125-17.9% 9,836 7,413-24.6% 23,108 9,006-61.0% 4,189 7,414 77.0% 1,036 3,464 234.5% (ii) 30

3,335 3,287 48 6,902 52,976 1,000 SMART specific measurable achievable realistic timed (iii) I I II/III II II I II/ 31

III II/III 1.1 I I RaQualia Pharma Inc. 40 36 27 3 26 (iv) GMP GMP 6 32

100% GMP (II) (i) (ii) 33

1 2) 8,000 10,000 3 34

4 (III) 35

1,773.5 21.8% 1,387.7 385.8 1,312.1 363.3 94.6% 98.1 23.0% 75.6 5.4% 460.3 33.2% 927.4 1,278.9 351.5 72.1% 66.8% GMP 36

615.3 465.0 150.3 6.1 55.9 253.2 14.4% 216.7 71.6 48.9 1,682.3 47.1% 890.5 240.5 28.3% 172.5 1,441.7 50.2% 718.0 37

1,451.6 49.3% 736.0 547.0 18.6% 9.8 18.0 2,678.3 2,282.4 2,484.1 1,959.3 2,449.0 2,449.0 35.1 2,484.1 2,111.0 38

2,678,311 2,282,370 (8,280) (8,280) 2,670,031 2,274,090 747.0 972.3 225.3 265.9 233.0 98 73 2,062.6 11.2 0.5% 39

2,797.1 2,817.1 1,294.7 630.4 242.4 40

41

134.4 101.7 32.7 NHPEA IV Health Holding B.V. NHPEA IV Health Euromax Holdings Limited Euromax Euromax NHPEA IV Health 23.71% 38.14% 38.14% 26.6 172.4 Euromax 6.3 40.9 NHPEA IV Health 10.1 65.6 10.1 65.6 Euromax NHPEA IV Health Euromax 18.91% NHPEA IV Health NHPEA IV Health Euromax 38.14% 57.06% 4.80% 2,782 134.9 112.1 42

2410 43

96 58,633,000 13,699,000 $1.64 $1.59 22.3 18.9 44,934,000 $1.66 $1.60 74.2 62.9 58,633,000 96.5 81.8 493,214,000 289,298,000 9.5% 44

1.4 1.6 1.4 183 22 (http://www. hkexnews.hk) (http://www.sihuanpharm.com) http://www. sihuanpharm.com) (http://www.hkexnews.hk) 45

183 22 sihuanpharm-ecom@hk.tricorglobal.com 46